Protara Therapeutics Inc (TARA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.77
• Market Cap: $319.38M
• EPS: $-1.39
• 52-Week High: $7.82
• 52-Week Low: $2.77

Market Sentiment

Protara Therapeutics Inc currently has a Bullish sentiment score of 0.15.

About Protara Therapeutics Inc

Protara Therapeutics, Inc. (TARA) is a clinical-stage biopharmaceutical company headquartered in New York, dedicated to developing innovative therapies for cancer and rare diseases. The company's proprietary product candidates utilize advanced drug delivery technologies designed to improve therapeutic outcomes for patients with significant unmet medical needs. With a strong pipeline supported by strategic collaborations, Protara is well-positioned to advance transformative treatments while pr...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Protara Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TARA pay dividends?

Protara Therapeutics Inc (TARA) does not currently pay a regular dividend.

What is TARA's market cap?

Protara Therapeutics Inc (TARA) has a market capitalization of $319.38M with a current stock price of $5.77.